Given that FLT3 expression is highly restricted on lymphoid progenitors, it is possible that the established role of FLT3 in the regulation of B and T lymphopoiesis reflects its high expression and role in regulation of lymphoid-primed multipotent progenitors (LMPPs) or common lymphoid progenitors (CLPs). We generated a Flt3 conditional knock-out (Flt3 fl/fl ) mouse model to address the direct role of FLT3 in regulation of lymphoidrestricted progenitors, subsequent to turning on Rag1 expression, as well as potentially ontogeny-specific roles in B and T lymphopoiesis. Our studies establish a prominent and direct role of FLT3, independently of the established role of FLT3 in regulation of LMPPs and CLPs, in regulation of fetal as well as adult early B cell progenitors, and the early thymic progenitors (ETPs) in adult mice but not in the fetus. Our findings highlight the potential benefit of targeting poor prognosis acute B-cell progenitor leukaemia and ETP leukaemia with recurrent FLT3 mutations using clinical FLT3 inhibitors.
kinase (Matthews et al, 1991; Rosnet et al, 1991; Rosnet et al, 1993) . Its ligand, FLT3 ligand (FLT3L) exists in a soluble as well as membrane-bound form (Lyman et al, 1995; Lyman & Jacobsen, 1998) . Studies in mice have established that FLT3 and FLT3L play an important role in lymphopoiesis (Lyman & Jacobsen, 1998; McKenna et al, 2000; Sitnicka et al, 2002; Tsapogas et al, 2017) . Although not expressed on haematopoietic stem cells (HSCs), FLT3 expression is initiated on multipotent progenitors (MPPs) and sustained on common lymphoid progenitors (CLPs), but is only expressed on the very earliest B-cell and T-cell progenitors (Wasserman et al, 1995; Adolfsson et al, 2001 Adolfsson et al, , 2005 Sitnicka et al, 2002; Boyer et al, 2011; Buza-Vidas et al, 2011; Luc et al, 2012) . Lymphoid-primed multipotent progenitors (LMPPs) express the highest levels of FLT3 (Adolfsson et al, 2005) , and FLT3 plays a key role in LMPP and CLP maintenance (Sitnicka et al, 2002 . As recently highlighted (Tsapogas et al, 2017) , because no Flt3 conditional knockout mouse has been generated, it remains unclear to what degree the reductions observed in B lymphocyte and thymocyte progenitors in mice with germ line deletion of FLT3 or FLT3L (Mackarehtschian et al, 1995; Sitnicka et al, 2003 Sitnicka et al, , 2007 , are secondary to loss of LMPPs and/or CLPs prior to becoming programmed for lymphoid-restricted development, or also reflect a distinct role of FLT3 also in already lymphoid-restricted progenitors. In fact, the expression of FLT3 in the B-and T-lymphocyte lineages, is restricted to the earliest pre-proB and early thymic progenitors (ETPs), respectively (Wasserman et al, 1995; Mansson et al, 2010; Luc et al, 2012) , progenitors suggested largely to represent not fully lymphoid-restricted progenitors (Rumfelt et al, 2006; Luc et al, 2012) . Establishing to what degree FLT3 plays a direct role in regulating already lymphoid-programmed progenitors, is of particular relevance for the high prevalence of two types of FLT3 driver mutations, internal tandem duplication (ITD) and recurrent FLT3 pointmutations, both associated with a poor clinical outcome in acute leukaemia (Stirewalt & Radich, 2003; Tsapogas et al, 2017) , including distinct ETP and B-cell progenitor leukaemia (Armstrong et al, 2004; Neumann et al, 2013) .
Furthermore, cytokine receptors and their ligands are thought to play distinct roles at different stages of development, and this has been also specifically suggested for FLT3 and FLT3L (Vosshenrich et al, 2003; Boiers et al, 2013; Beaudin et al, 2016) . To more specifically address progenitor stage-and ontogeny-specific roles of FLT3 in regulation of normal lymphopoiesis, we generated a Flt3 floxed/floxed conditional knock-out (Flt3 fl/fl ) mouse line, allowing us to specifically target FLT3 deletion in a temporal and spatial manner.
Methods and materials

Animals
The Flt3 floxed/floxed conditional knock-out (Flt3 fl/fl ) mouse line was generated using a DNA targeting construct in which the genomic fragment of the mouse Flt3 gene has exon 15 flanked by LoxP sites (flox) and with an Frt-neomycin-Frt cassette inserted into intron 15 of the mouse Flt3 gene. The IB10/C embryonic stem (ES) cell line (E14 subclone 129/Ola) was electroporated with the targeting construct and targeted clones selected using neomycin. Correctly-targeted ES clones were introduced into C57BL6 blastocysts by injection into the blastocyst cavity. Injected blastocysts were then transplanted to the uterus of pseudo-pregnant foster mothers.
Offspring positive for the floxed Flt3 allele were then crossed with Flp-deleter mice to remove the neomycin cassette. control littermates. For timed pregnancies, mice were mated late afternoon and females were checked the following morning for the presence of a vaginal plug designated as embryonic day 0Á5 (E0Á5). All mice were maintained under specific pathogen-free conditions at Lund University Animal Facility. The Ethical Committee at Lund University approved all performed experiments.
Dissections and cell preparations
The fetal liver (FL) and fetal thymus were dissected and mechanically disrupted with a syringe. Bone marrow (BM) cells were extracted from femora and tibia using a mortar. Peritoneal cavity lavage was performed using 10 ml of phosphate-buffered saline (PBS) (Thermo Fisher Scientific Inc, Logan, UT, USA) containing 5% of Fetal Bovine Serum (FBS) (Hyclone, Logan, UT, USA). Single-cell suspensions were prepared in PBS containing 5% of FBS and filtered through a 70-lm cell strainer (BD Biosciences, San Jose, CA, USA). Cells were counted with the Sysmex (KX-21N) Haematology analyser (Sysmex Corporation Europe GmbH, Norderstedt, Germany).
Flow cytometry and fluorescence-activated cell sorting (FACS) the analysis. Samples were analysed on an LSRII (BD Biosciences) and analysis was performed using FlowJo software (version 9.3; TreeStar, Ashland, OR, USA). For all the flow cytometry profiles shown, singlet viable cells were first gated as lineage negative and further gating is indicated with arrows. 
Transplantation assay
Lethally irradiated (900 cGy) 12-to 16-week-old C57BL/6 CD45.1 wild type (WT) recipient mice were transplanted intravenously with 2 9 10 6 cells unfractionated BM cells from 
Statistics
Prism software (GraphPad Software Inc., La Jolla, CA, USA) was used for all statistical analysis. Statistical significances were determined using an unpaired Mann-Whitney test. The significance level was set at P < 0Á05.
Results
Requirement for FLT3 during adult haematopoiesis
To investigate the requirement for FLT3 at different stages of development and distinct haematopoietic progenitor stages, we generated mice in which loxP sites had been inserted into the flanking introns of exon 15 of the Flt3 gene (Flt3
). Exon 15 encodes for a kinase ATP binding domain required for signal transduction upon ligand binding after dimerization and autophosphorylation of the FLT3 receptor (Ubersax & Ferrell, 2007 Figure S1B ).
Moreover, in agreement with previous studies of conventional germ-line Flt3 and Flt3l knockout mice (in which Flt3 or Flt3l expression is permanently disrupted in the entire mouse) (Mackarehtschian et al, 1995; McKenna et al, 2000; Sitnicka et al, 2003 Sitnicka et al, , 2007 (CD45.2) mice (n = 6 per genotype) together with 2 9 10 6 cells unfractionated BM competitor cells from WT CD45.1 mice, analysed 8 weeks post-transplantation and 4 weeks after pIpC injection. *P < 0Á05; **P < 0Á01; ***P < 0Á001. As previous studies have suggested that FLT3 might have distinct roles in adult and fetal haematopoiesis (Vosshenrich et al, 2003; Boiers et al, 2013; Beaudin et al, 2016) , we next specifically investigated the role of FLT3 in adult 
Flt3
fl/fl and Rag1 cre/+ Flt3 fl/fl mice (n = 7 mice per genotype in 2 experiments). *P < 0Á05; **P < 0Á01; ***P < 0Á001; ns, not significant.
haematopoiesis by crossing Flt3 fl/fl with Mx1-cre cre/+ mice in which Cre is only expressed upon induction with either interferon-a or the interferon inducer pIpC (Kuhn et al, 1995 (Fig 1A) .
No change was observed in total BM cellularity ( Figure S2A ), nor in the number of HSCs (Lin Fig 1B) , in agreement with the lack of FLT3 expression on mouse HSCs (Sitnicka et al, 2002; Buza-Vidas et al, 2009; Beaudin et al, 2014 Beaudin et al, , 2016 . In contrast, CD48 + CD150
À MPPs, containing LMPPs normally expressing the highest levels of FLT3 (Adolfsson et al, 2005; Mead et al, 2013) , were distinctly reduced (Fig 1B) . Notably, despite of the loss of FLT3 expression, CLP numbers were unaffected in adult Mx1 cre/+ Flt3 fl/fl mice 4 weeks following pIpC treatment (Fig 1B) , suggesting that the maintenance of adult CLPs is less dependent on FLT3 than LMPPs. Surprisingly, and in contrast to adult mice with constitutive knock-out of FLT3 (Mackarehtschian et al, 1995) , no changes were observed in distinct stages of B-cell progenitors (ProB: Lin Fig 1C) . In contrast, while no significant change was observed in total thymus cellularity ( Figure S2B ), a clear reduction was observed in the ETP (Lin (Fig 1F-H , Figure S2C -E). Thus, FLT3 plays an important role in sustaining multiple stages of lympho-myeloid progenitors in adult haematopoiesis.
Requirement for FLT3 after initiation of lymphoid lineage programme
Previously reported reductions in the earliest B-and T-lymphoid progenitors in conventional Flt3 knockout mice could potentially be secondary to reductions in high FLT3- (Fig 2E) as well as ETPs in the thymus were significantly reduced (Fig 2F; Figure S3B ), to a similar degree as in Vav1 cre/+ Flt3 fl/fl mice ( Figure S1D -E), establishing a strict requirement for FLT3, independently of LMPPs and CLPs, and after initiation of lymphoid-restricted gene expression in adult haematopoiesis. Previous studies have suggested that the cytokine requirement might be distinct for fetal and adult lymphoid progenitors (Carvalho et al, 2001; Vosshenrich et al, 2003; Hesslein et al, 2006; Beaudin et al, 2016; Zriwil et al, 2016) . Moreover, LMPPs in the FL express higher levels of lymphoid genes, including Rag1, when compared to their adult counterparts (Boiers et al, 2013 (Fig 3C-D) , similar to what was observed in the adult BM. Notably, the earliest ProB cell progenitors emerging in the FL at this stage, were reduced by almost 90%, demonstrating Fig 3E, Figure S4A -B). In contrast, the earliest thymic progenitors in the E14.5 thymus were unaffected in Rag1 cre/+ Flt3 fl/fl embryos ( Fig 3F, Figure S4C ). Even when E14.5 CD45.2 Rag1 cre/+ Flt3 fl/fl FL cells were competitively transplanted into lethally-irradiated adult wild-type (WT) CD45.1 recipients, we observed no impact of Flt3 deficiency on the earliest LMPP and CLP progenitor compartments (Fig 3G) , while early B-and T-cell progenitors were distinctly reduced (Fig 3H-I , Figure S4D -F), again supporting a distinct role of FLT3 in early lymphoid progenitors subsequent to the initiation of lymphoid lineage programming.
Role of FLT3 in maintenance of distinct B cell subsets
As we observed a strong impact of lymphoid-restricted deletion of FLT3 on B-progenitor cell maintenance in the embryo as well as in adult haematopoiesis, we next investigated to what degree the generation and maintenance of the preferentially fetal-derived mature B1a and Marginal Zone B (MZB) cells (Hardy & Hayakawa, 1991; Kantor et al, 1992; Yoshimoto et al, 2011) as well as conventional B2 cells which are also produced during adult haematopoiesis (Hao & Rajewsky, 2001) (Fig 4E-F) , establishing an important role of FLT3 for the homeostasis of each of these distinct B cell populations from already lymphoidrestricted progenitors.
Discussion
Despite the established role of FLT3 in B-and T-lymphopoiesis (Mackarehtschian et al, 1995; McKenna et al, 2000; Sitnicka et al, 2003 Sitnicka et al, , 2007 Buza-Vidas et al, 2007) , and the involvement of recurrent FLT3 mutations in acute B-and Tcell progenitor leukaemia (Carow et al, 1996; Gilliland & Griffin, 2002; Armstrong et al, 2004; Neumann et al, 2013) , it has remained unclear whether lymphoid-restricted progenitors are directly dependent on FLT3. This is particularly relevant because FLT3 expression is highest and critically important on the earliest adult lympho-myeloid LMPPs, of which only a fraction express low levels of Rag1 (Adolfsson et al, 2005) , whereas only the very earliest T-and B-cell progenitors express FLT3 (Wasserman et al, 1995; Mansson et al, 2010; Luc et al, 2012) . Herein, we developed a Flt3 conditional knockout mouse model to specifically investigate a potential requirement for FLT3 in progenitors already programmed for lymphopoiesis, as determined by high Rag1 expression, as well as potentially distinct roles in fetal and adult lymphopoiesis. Our studies confirmed that while having no role in the regulation of HSCs, FLT3 is important for sustaining normal numbers of LMPPs in adult BM as well as ETPs in the adult thymus. In contrast, CLPs were only minimally affected when induced to loose FLT3 expression in adult mice, establishing that LMPPs are more dependent on intact FLT3 expression and function than CLPs in adult steady-state haematopoiesis. Notably, B-cell progenitor numbers were also unaffected upon inducible pan-haematopoietic deletion of FLT3 in adult mice. Nevertheless, molecular analysis of B-cell progenitors 2) mice (n = 5 per genotype) together with 2 9 10 6 cells unfractionated E14.5 FL competitor cells from wild type CD45.1 embryos, analysed 8 weeks post-transplantation. *P < 0Á05; **P < 0Á01; ***P < 0Á001. mice, in the absence of an impact on LMPPs and CLPs. This is of considerable significance, given that FLT3 expression in the B and T cell lineages is restricted to the very earliest B-and T-cell progenitors, pre-proB cells (Wasserman et al, 1995) and ETPs (Luc et al, 2012) , respectively. Importantly, these progenitors are likely to also be key cellular targets for recurrent FLT3 driver mutations in patients with acute B-cell progenitor and ETP leukaemia (Carow et al, 1996; Armstrong et al, 2004; Neumann et al, 2013) . Our findings therefore highlight the potential benefit of targeting these leukaemias with clinical FLT3 inhibitors (Annesley & Brown, 2014 mice establish a critical role for FLT3 in the maintenance of fetal-derived B1a and MZB cells (Hardy & Hayakawa, 1991; Kantor et al, 1992; Yoshimoto et al, 2011) as well as conventional B2 cells (Hao & Rajewsky, 2001) . Previous studies have shown that the important role of FLT3 in fetal B1 and B2 lymphopoiesis is even more evident in the absence of interleukin 7 (IL7). Specifically, in the absence of the IL7 ligand and FLT3 ligand, fetal and adult B lymphopoiesis is almost entirely lost, suggesting that thymic stromal lymphoprotein (TSLP), also acting through the IL7 receptor, is unable to rescue B cell development in the absence of FLT3 ligand and IL7 (Sitnicka et al, 2003; Jensen et al, 2008) .
In conclusion, through lymphoid-restricted and ontogenyspecific deletion of FLT3 expression and function, we establish that the important role of FLT3 in fetal and adult B-and T-lymphopoiesis is, in fact, not primarily explained by its role in regulation of LMPPs and CLPs, but rather by a direct and more prominent role in the regulation of the very earliest Rag1 expressing B-and T-cell progenitors, which are likely to be primary cellular targets for recurrent FLT3 mutations in clinically distinct B-and T-cell progenitor cell leukaemia. 
FLT3: Spatial and Temporal Roles in Lymphopoiesis
Declaration of interest
The authors declare no competing financial interests.
Supporting Information
Additional supporting information may be found online in the Supporting Information section at the end of the article. Figure S1 . Provides data validating the model. Figure S2 . Provides data that extends the findings in Fig 1 . Figure S3 . Provides data that extends the findings in Figs 2, 3 and 4. Figure S4 . Provides data that extends the findings in Fig 3 . Table S1 . Provides the list of antibodies used in the study.
